Recommendation on test readiness criteria for new approach methods in toxicology: Exemplified for developmental neurotoxicity

Anna Bal-Price, Helena T. Hogberg, Kevin M. Crofton, Mardas Daneshian, Rex E. FitzGerald, Ellen Fritsche, Tuula Heinonen, Susanne Hougaard Bennekou, Stefanie Klima, Aldert H. Piersma, Magdalini Sachana, Timothy J. Shafer, Andrea Terron, Florianne Monnet-Tschudi, Barbara Viviani, Tanja Waldmann, Remco H.S. Westerink, Martin F. Wilks, Hilda Witters, Marie Gabrielle ZurichMarcel Leist

Research output: Contribution to journalArticle

Abstract

Multiple non-animal-based test methods have never been formally validated. In order to use such new approach methods (NAMs) in a regulatory context, criteria to define their readiness are necessary. The field of developmental neurotoxicity (DNT) testing is used to exemplify the application of readiness criteria. The costs and number of untested chemicals are overwhelming for in vivo DNT testing. Thus, there is a need for inexpensive, high-throughput NAMs, to obtain initial information on potential hazards, and to allow prioritization for further testing. A background on the regulatory and scientific status of DNT testing is provided showing different types of test readiness levels, depending on the intended use of data from NAMs. Readiness criteria, compiled during a stakeholder workshop, uniting scientists from academia, industry and regulatory authorities are presented. An important step beyond the listing of criteria, was the suggestion for a preliminary scoring scheme. On this basis a (semi)-quantitative analysis process was assembled on test readiness of 17 NAMs with respect to various uses (e.g. prioritization/screening, risk assessment). The scoring results suggest that several assays are currently at high readiness levels. Therefore, suggestions are made on how DNT NAMs may be assembled into an integrated approach to testing and assessment (IATA). In parallel, the testing state in these assays was compiled for more than 1000 compounds. Finally, a vision is presented on how further NAM development may be guided by knowledge of signaling pathways necessary for brain development, DNT pathophysiology, and relevant adverse outcome pathways (AOP).

Original languageEnglish (US)
Pages (from-to)306-352
Number of pages47
JournalALTEX
Volume35
Issue number3
DOIs
StatePublished - 2018

Keywords

  • developmental in vitro neurotoxicity testing
  • quality assurance
  • regulatory toxicology
  • toxicity screening

ASJC Scopus subject areas

  • Pharmacology
  • Medical Laboratory Technology

Fingerprint Dive into the research topics of 'Recommendation on test readiness criteria for new approach methods in toxicology: Exemplified for developmental neurotoxicity'. Together they form a unique fingerprint.

  • Cite this

    Bal-Price, A., Hogberg, H. T., Crofton, K. M., Daneshian, M., FitzGerald, R. E., Fritsche, E., Heinonen, T., Hougaard Bennekou, S., Klima, S., Piersma, A. H., Sachana, M., Shafer, T. J., Terron, A., Monnet-Tschudi, F., Viviani, B., Waldmann, T., Westerink, R. H. S., Wilks, M. F., Witters, H., ... Leist, M. (2018). Recommendation on test readiness criteria for new approach methods in toxicology: Exemplified for developmental neurotoxicity. ALTEX, 35(3), 306-352. https://doi.org/10.14573/altex.1712081